Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface

  1. Lei Liu
  2. Zhiran Fan
  3. Xavier Rovira
  4. Li Xue
  5. Salomé Roux
  6. Isabelle Brabet
  7. Mingxia Xin
  8. Jean-Philippe Pin  Is a corresponding author
  9. Jianfeng Liu  Is a corresponding author
  10. Philippe Rondard  Is a corresponding author
  1. Huazhong University of Science and Technology, China
  2. Spanish National Research Council, Spain
  3. University of Montpellier, CNRS, INSERM, France

Abstract

G protein-coupled receptors (GPCRs) are among the most promising drug targets. They often form homo- and heterodimers with allosteric cross-talk between receptor entities, which contributes to fine tuning of transmembrane signaling. Specifically controlling the activity of GPCR dimers with ligands is a good approach to clarify their physiological roles and to validate them as drug targets. Here, we examined the mode of action of positive allosteric modulators (PAMs) that bind at the interface of the transmembrane domains of the heterodimeric GABAB receptor. Our site-directed mutagenesis results show that mutations of this interface impact the function of the three PAM tested. The data support the inference that they act at the active interface between both transmembrane domains, the binding site involving residues of the TM6s of the GABAB1 and the GABAB2 subunit. Importantly, the agonist activity of these PAMs involves a key region in the central core of the GABAB2 transmembrane domain, which also controls the constitutive activity of the GABAB receptor. This region corresponds to the sodium ion binding site in class A GPCRs that controls the basal state of the receptors. Overall, these data reveal the possibility of developing allosteric compounds able to specifically modulate the activity of GPCR homo- and heterodimers by acting at their transmembrane interface.

Data availability

Figure 2- Source Data 1 contain the numerical data used to generate the figures;Figure 3 - Source Data 1 contain the numerical data used to generate the figures;Figure 4 - Source Data 1 contain the numerical data used to generate the figures;Figure 5 - Source Data 1 contain the numerical data used to generate the figures.

Article and author information

Author details

  1. Lei Liu

    Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Huazhong University of Science and Technology, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9824-9570
  2. Zhiran Fan

    Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Huazhong University of Science and Technology, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9543-1211
  3. Xavier Rovira

    MCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Spanish National Research Council, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  4. Li Xue

    University of Montpellier, CNRS, INSERM, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Salomé Roux

    University of Montpellier, CNRS, INSERM, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6106-4863
  6. Isabelle Brabet

    University of Montpellier, CNRS, INSERM, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Mingxia Xin

    Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Huazhong University of Science and Technology, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Jean-Philippe Pin

    University of Montpellier, CNRS, INSERM, Montpellier, France
    For correspondence
    jean-philippe.pin@igf.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.
  9. Jianfeng Liu

    Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Huazhong University of Science and Technology, Wuhan, China
    For correspondence
    jfliu@mail.hust.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0284-8377
  10. Philippe Rondard

    University of Montpellier, CNRS, INSERM, Montpellier, France
    For correspondence
    philippe.rondard@igf.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1134-2738

Funding

Ministry of Science and Technology of the People's Republic of China (2018YFA0507003)

  • Jianfeng Liu

Agence Nationale de la Recherche (ANR-09-PIRI-0011)

  • Philippe Rondard

Fondation pour la recherche médicale FRM (FRM team: DEQ20170326522)

  • Jean-Philippe Pin

Spanish Ministry of Economy (SAF2015-74132-JIN)

  • Xavier Rovira

National Natural Science Foundation of China (81720108031)

  • Jianfeng Liu

National Natural Science Foundation of China (81872945)

  • Jianfeng Liu

National Natural Science Foundation of China (31721002)

  • Jianfeng Liu

National Natural Science Foundation of China (31420103909)

  • Jianfeng Liu

Ministry of Education of the People's Republic of China (B08029)

  • Jianfeng Liu

Centre National de la Recherche Scientifique (PICS n{degree sign}07030)

  • Philippe Rondard

Centre National de la Recherche Scientifique (PRC n{degree sign}1403)

  • Philippe Rondard

Institut National de la Santé et de la Recherche Médicale (IRP Brain Signal)

  • Philippe Rondard

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Liu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,164
    views
  • 443
    downloads

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lei Liu
  2. Zhiran Fan
  3. Xavier Rovira
  4. Li Xue
  5. Salomé Roux
  6. Isabelle Brabet
  7. Mingxia Xin
  8. Jean-Philippe Pin
  9. Jianfeng Liu
  10. Philippe Rondard
(2021)
Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface
eLife 10:e70188.
https://doi.org/10.7554/eLife.70188

Share this article

https://doi.org/10.7554/eLife.70188

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Joar Esteban Pinto Torres, Mathieu Claes ... Yann G-J Sterckx
    Research Article

    African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

    1. Biochemistry and Chemical Biology
    Jianheng Fox Liu, Ben R Hawley ... Samie R Jaffrey
    Tools and Resources

    N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.